Navigation Links
Pharmaceutical Budget and Staffing: Powerful New Metrics-Based Study
Date:2/7/2008

CHAPEL HILL, N.C., Feb. 7 /PRNewswire/ -- Falling stock prices, devaluing dollar, soaring gas prices, and the slumping real estate market are just a few of the symptoms of the recession hitting the U.S. economy. While a recession will impact all industries, it may have a deeper impact on pharma and biotech companies as they have already been dealing with increasing pricing and regulatory pressures and decreasing numbers of newly approved therapies. Given the current environment, it is imperative for companies to maintain the appropriate mix of budgets and staffing to meet corporate objectives.

The current report, U.S. Pharmaceutical Budget and Staffing Excellence: Benchmarking the Resources Required to Drive Productivity and Growth, can be an invaluable resource allowing pharmaceutical and biotech executives to critically assess key business functions and resources against thirty-six top pharma and biotech companies. The rich metrics contained in this comprehensive report emanate from survey responses from staffing executives at such elite pharmaceutical and biotech companies as Abbott Labs, AstraZeneca, Bristol-Myers Squibb, J&J, Eli Lilly GlaxoSmithKline, Merck, Novartis, Pfizer, Roche and Sanofi-Aventis.

Executive insight across seven critical functional areas, including:

* Marketing Operations

* Marketing Services

* Sales Support

* Managed Care

* State & Government Affairs

* Finance

* Legal and Compliance

Sampling of the key findings harnessed from the report include:

* Marketing Services groups support an average of 7.8 brands with 6.7 FTEs

allocated per brand promoted

* Sales Support groups allocate approximately $460,000, including labor,

overhead and outsourcing, per sales support FTE

* Managed Care groups report an average of 18 FTEs allocated to Customer

Marketing Strategy

* Finance budgets as a percentage of sales average 1.33%

* Legal and Compliance groups indicate an average spend of $199,702 per

FTE

To download a free excerpt of U.S. Pharmaceutical Budget and Staffing Excellence visit http://www3.best-in-class.com/rr827.htm. For more information, contact Cameron Tew at (919) 767-9246 or ctew@best-in-class.com.

BEST PRACTICES, LLC is a benchmarking and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information, call (919) 403-0251 or visit http://www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Huffman Engineering, Inc. , ... Wonderware Certified System Integrator Partner. Huffman Engineering is the only Nebraska-based company ... System Integrator Partner certification gives customers confidence that our engineers are fully trained ...
(Date:12/7/2016)... EDMONTON , Dec. 7, 2016 /PRNewswire/ - ... the development and commercialization of immunotherapeutic products for ... has entered into an Antibody Manufacturing Development Program ... , USA) for its oregovomab antibody product. ... its Phase IIb clinical study in ovarian cancer ...
(Date:12/7/2016)... Ontario , Dec. 7, 2016  Nordion, ... with General Atomics (GA), welcome today,s award by ... Nuclear Security Administration (NNSA) of the Phase II ... project with Nordion and the University of Missouri ... II funding will support the establishment of a ...
(Date:12/7/2016)... The report "Acrylic Processing Aid Market by Polymer Type (PVC), Fabrication Process (Extrusion, Injection Molding), ... 2026", published by MarketsandMarkets, the global market size was USD 645.4 Million in ... of CAGR of 6.2% between 2016 and 2026. ... ... , , ...
Breaking Biology Technology:
(Date:12/5/2016)... 2016  The Office of Justice Programs, National ... Scans Enhance or Replace Medico Legal Autopsies?" on ... or replacing forensic autopsies with postmortem X-ray computed ... In response to recommendations made by The National ... scans as a potential component of medicolegal death ...
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a privately ... products for the objective detection of concussion and other ... has successfully completed a meeting with the U.S. Food ... blood test Pre-Submission Package. During the meeting company representatives ... as a precursor to commencement of a planned pilot ...
(Date:11/22/2016)... According to the new market research report "Biometric ... Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, ... is expected to grow from USD 10.74 Billion in 2015 to reach ... and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):